Skip to Main Content

Practice Impact Extra

Dr. Bernard Monteleone, former Head of Cardiology at St. Francis Hospital in New York, gives an informed analysis of highly-anticipated trials and whether or not their findings could impact clinical practice guidelines and reduce the risk of cardiovascular disease.

You may follow this podcast on Apple Podcasts, Spotify, Stitcher, iHeartRadio, or copy the RSS Feed and paste it into your podcast application: https://feeds.soundcloud.com/users/soundcloud:users:707224624/sounds.rss

New! Episode 70: Ivabradine
By Bernard Monteleone, MD
4:13
New! Episode 69: Cardiovascular Health in Women
By Bernard Monteleone, MD
4:14
New! Episode 68: Advanced Lipoprotein Testing
By Bernard Monteleone, MD
3:15
New! Episode 67: Fluoroquinolones
By Bernard Monteleone, MD
3:34
New! Episode 66: Diabetes and EKG Abnormalities
By Bernard Monteleone, MD
3:19
New! Episode 65: Heart Benefits of Green Tea
By Bernard Monteleone, MD
3:18
New! Episode 64: Heart Benefits of Coffee
By Bernard Monteleone, MD
3:14
New! Episode 63: Covid Patients and Elevated Troponin
By Bernard Monteleone, MD
4:00
New! Episode 62: Hypertension and Sex Differences
By Bernard Monteleone, MD
4:30
New! Episode 61: SCORED and Cardiovascular Events
By Bernard Monteleone, MD
2:52
New! Episode 60: SOLOIST and SCORED Trials
By Bernard Monteleone, MD
3:14
New! Episode 59: VITAL - RHYTHM Trial
By Bernard Monteleone, MD
2:59
New! Episode 58: The STRENGTH and OMNI Trials
By Bernard Monteleone, MD
4:19
New! Episode 57: Alcohol and Atrial Fibrillation
By Bernard Monteleone, MD
3:53
New! Episode 55: 3D Echo to Improve Cancer Treatment
By Bernard Monteleone, MD
3:50
New! Episode 54: The HARP-MINOCA study
By Bernard Monteleone, MD
3:09
New! Episode 53: RHAPSODY Trial
By Bernard Monteleone, MD
3:09
New! Episode 52: TIPS-3 Trial + Aspirin
By Bernard Monteleone, MD
3:26
New! Episode 51: TIPS-3 Trial
By Bernard Monteleone, MD
3:34
Episode 45: COVID and Athletes
By Bernard Monteleone, MD
2:54
Episode 49: Beta Blocker Therapy
By Bernard Monteleone, MD
5:01
Episode 35: COVID and Athletes
By Bernard Monteleone, MD
4:12
Episode 36: Reality Trial
By Bernard Monteleone, MD
3:43
Episode 37: EMPEROR: Reduced Trial
By Bernard Monteleone, MD
3:30
Episode 38: PARALLAX Study
By Bernard Monteleone, MD
3:25
Episode 39: EVAPORATE Trial Follow-Up
By Bernard Monteleone, MD
2:56
Episode 40: EAST: AFNET
By Bernard Monteleone, MD
2:52
Episode 22: Prevention after ESUS
By Bernard Monteleone, MD
4:55
Episode 23: Anticoagulants and Bone Health
By Bernard Monteleone, MD
3:53
Episode 25: FOURIER and Evolocumab
By Bernard Monteleone, MD
3:46
Episode 26: Coconut Oil and CVD Risk
By Bernard Monteleone, MD
3:48
Episode 27: Cardiac Function Post Covid 19
By Bernard Monteleone, MD
3:13
Episode 28: Bempedoic Acid and Diabetes
By Bernard Monteleone, MD
3:34
Episode 29: COAPT Trial
By Bernard Monteleone, MD
5:20
Episode 19: COVID AND Anticoagulants
By Bernard Monteleone, MD
3:15
Episode 20: ACE and COVID: Four Studies
By Bernard Monteleone, MD
5:02
Episode 06: The ODYSSEY Trial
By Bernard Monteleone, MD
4:30
Episode 04: DAPA2 Trial and the Elderly
By Monteleone Bernard, MD
3:05
Back to Top